Tracking retention and transport of ultrafine polystyrene in an asthmatic mouse model using positron emission tomography

Heather A. Enright, Jennifer M. Bratt, Andrew P. Bluhm, Nicholas Kenyon, Angelique Y. Louie

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Upon exposure to particulates, asthmatic individuals are more susceptible to deleterious health effects and increased morbidity and mortality when compared to healthy individuals. These effects are not limited to the respiratory system; increases in acute cardiovascular events have been observed. The development of extrapulmonary illnesses has led to interest in determining whether particles move out of the lungs and whether transport of particles differs for asthmatic individuals. Differences in particle deposition and retention in asthmatic versus normal subjects have been explored in the literature using the gamma camera, a two-dimensional imaging technique. Herein we report the deposition and fate of 64Cu-labeled 100 nm polystyrene particles in a mouse model of asthma using positron emission tomography (PET). All animals were handled humanely under an approved protocol (UC Davis Institutional Animal Care and Use Committee). Particles were administered by intratracheal instillation and animals were imaged over 48 hours using PET. Biodistribution was determined from images using Regions of Interest (ROI) analysis. After 48 hours, for the asthmatic animals, we observed that ∼28% of the initial dose is cleared from the lungs; particle accumulation in small amounts is evident in the GI (gastrointestinal) tract, liver, and bladder. This decrease in lung retention is significantly different when compared to the normal mouse (∼11%DD), which showed minimal particle transport out of the lung (P < 0.001). This study indicates that ultrafine particles (UFP) undergo enhanced transport out of the lungs in an asthma model. This observed transport may facilitate the adverse peripheral effects associated with particulate exposure.

Original languageEnglish (US)
Pages (from-to)304-313
Number of pages10
JournalExperimental Lung Research
Volume39
Issue number7
DOIs
StatePublished - Sep 2013

Fingerprint

Positron emission tomography
Polystyrenes
Positron-Emission Tomography
Animals
Lung
Respiratory system
Asthma
Animal Care Committees
Gamma Cameras
Liver
Respiratory System
Cameras
Health
Gastrointestinal Tract
Imaging techniques
Urinary Bladder
Ultrafine
Morbidity
Mortality

Keywords

  • Biodistribution
  • Imaging
  • Lung
  • Particulate matter
  • Ultrafine particles

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Molecular Biology
  • Clinical Biochemistry

Cite this

Tracking retention and transport of ultrafine polystyrene in an asthmatic mouse model using positron emission tomography. / Enright, Heather A.; Bratt, Jennifer M.; Bluhm, Andrew P.; Kenyon, Nicholas; Louie, Angelique Y.

In: Experimental Lung Research, Vol. 39, No. 7, 09.2013, p. 304-313.

Research output: Contribution to journalArticle

Enright, Heather A. ; Bratt, Jennifer M. ; Bluhm, Andrew P. ; Kenyon, Nicholas ; Louie, Angelique Y. / Tracking retention and transport of ultrafine polystyrene in an asthmatic mouse model using positron emission tomography. In: Experimental Lung Research. 2013 ; Vol. 39, No. 7. pp. 304-313.
@article{d99e1eb840c74644ae9adae5d68c249d,
title = "Tracking retention and transport of ultrafine polystyrene in an asthmatic mouse model using positron emission tomography",
abstract = "Upon exposure to particulates, asthmatic individuals are more susceptible to deleterious health effects and increased morbidity and mortality when compared to healthy individuals. These effects are not limited to the respiratory system; increases in acute cardiovascular events have been observed. The development of extrapulmonary illnesses has led to interest in determining whether particles move out of the lungs and whether transport of particles differs for asthmatic individuals. Differences in particle deposition and retention in asthmatic versus normal subjects have been explored in the literature using the gamma camera, a two-dimensional imaging technique. Herein we report the deposition and fate of 64Cu-labeled 100 nm polystyrene particles in a mouse model of asthma using positron emission tomography (PET). All animals were handled humanely under an approved protocol (UC Davis Institutional Animal Care and Use Committee). Particles were administered by intratracheal instillation and animals were imaged over 48 hours using PET. Biodistribution was determined from images using Regions of Interest (ROI) analysis. After 48 hours, for the asthmatic animals, we observed that ∼28{\%} of the initial dose is cleared from the lungs; particle accumulation in small amounts is evident in the GI (gastrointestinal) tract, liver, and bladder. This decrease in lung retention is significantly different when compared to the normal mouse (∼11{\%}DD), which showed minimal particle transport out of the lung (P < 0.001). This study indicates that ultrafine particles (UFP) undergo enhanced transport out of the lungs in an asthma model. This observed transport may facilitate the adverse peripheral effects associated with particulate exposure.",
keywords = "Biodistribution, Imaging, Lung, Particulate matter, Ultrafine particles",
author = "Enright, {Heather A.} and Bratt, {Jennifer M.} and Bluhm, {Andrew P.} and Nicholas Kenyon and Louie, {Angelique Y.}",
year = "2013",
month = "9",
doi = "10.3109/01902148.2013.819048",
language = "English (US)",
volume = "39",
pages = "304--313",
journal = "Experimental Lung Research",
issn = "0190-2148",
publisher = "Informa Healthcare",
number = "7",

}

TY - JOUR

T1 - Tracking retention and transport of ultrafine polystyrene in an asthmatic mouse model using positron emission tomography

AU - Enright, Heather A.

AU - Bratt, Jennifer M.

AU - Bluhm, Andrew P.

AU - Kenyon, Nicholas

AU - Louie, Angelique Y.

PY - 2013/9

Y1 - 2013/9

N2 - Upon exposure to particulates, asthmatic individuals are more susceptible to deleterious health effects and increased morbidity and mortality when compared to healthy individuals. These effects are not limited to the respiratory system; increases in acute cardiovascular events have been observed. The development of extrapulmonary illnesses has led to interest in determining whether particles move out of the lungs and whether transport of particles differs for asthmatic individuals. Differences in particle deposition and retention in asthmatic versus normal subjects have been explored in the literature using the gamma camera, a two-dimensional imaging technique. Herein we report the deposition and fate of 64Cu-labeled 100 nm polystyrene particles in a mouse model of asthma using positron emission tomography (PET). All animals were handled humanely under an approved protocol (UC Davis Institutional Animal Care and Use Committee). Particles were administered by intratracheal instillation and animals were imaged over 48 hours using PET. Biodistribution was determined from images using Regions of Interest (ROI) analysis. After 48 hours, for the asthmatic animals, we observed that ∼28% of the initial dose is cleared from the lungs; particle accumulation in small amounts is evident in the GI (gastrointestinal) tract, liver, and bladder. This decrease in lung retention is significantly different when compared to the normal mouse (∼11%DD), which showed minimal particle transport out of the lung (P < 0.001). This study indicates that ultrafine particles (UFP) undergo enhanced transport out of the lungs in an asthma model. This observed transport may facilitate the adverse peripheral effects associated with particulate exposure.

AB - Upon exposure to particulates, asthmatic individuals are more susceptible to deleterious health effects and increased morbidity and mortality when compared to healthy individuals. These effects are not limited to the respiratory system; increases in acute cardiovascular events have been observed. The development of extrapulmonary illnesses has led to interest in determining whether particles move out of the lungs and whether transport of particles differs for asthmatic individuals. Differences in particle deposition and retention in asthmatic versus normal subjects have been explored in the literature using the gamma camera, a two-dimensional imaging technique. Herein we report the deposition and fate of 64Cu-labeled 100 nm polystyrene particles in a mouse model of asthma using positron emission tomography (PET). All animals were handled humanely under an approved protocol (UC Davis Institutional Animal Care and Use Committee). Particles were administered by intratracheal instillation and animals were imaged over 48 hours using PET. Biodistribution was determined from images using Regions of Interest (ROI) analysis. After 48 hours, for the asthmatic animals, we observed that ∼28% of the initial dose is cleared from the lungs; particle accumulation in small amounts is evident in the GI (gastrointestinal) tract, liver, and bladder. This decrease in lung retention is significantly different when compared to the normal mouse (∼11%DD), which showed minimal particle transport out of the lung (P < 0.001). This study indicates that ultrafine particles (UFP) undergo enhanced transport out of the lungs in an asthma model. This observed transport may facilitate the adverse peripheral effects associated with particulate exposure.

KW - Biodistribution

KW - Imaging

KW - Lung

KW - Particulate matter

KW - Ultrafine particles

UR - http://www.scopus.com/inward/record.url?scp=84882949407&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882949407&partnerID=8YFLogxK

U2 - 10.3109/01902148.2013.819048

DO - 10.3109/01902148.2013.819048

M3 - Article

C2 - 23919375

AN - SCOPUS:84882949407

VL - 39

SP - 304

EP - 313

JO - Experimental Lung Research

JF - Experimental Lung Research

SN - 0190-2148

IS - 7

ER -